Transgenic mouse models for B-cell dominant autoimmune diseases

Current Opinion in Immunology

Volumn 9, Issue 6, 1997, Pages 846-850

  Murakami, Masao ^a   Honjo, Tasuku ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AUTOIMMUNE DISEASE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CLONAL ANERGY; CONTROLLED STUDY; IMMUNOLOGICAL TOLERANCE; INFECTION; MOUSE; MYASTHENIA GRAVIS; NONHUMAN; REVIEW; T LYMPHOCYTE; TRANSGENIC MOUSE;

EID: 0031461685     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(97)80188-4     Document Type: Article

References (38)

1. Izui S: Autoimmune hemolytic anemia. Curr Opin Immunol 1994, 6:926-930.
2. Willcox N: Myasthenia gravis. Curr Opin Immunol 1993, 5:910-917.
3. Linington C, Hohlfeld R: T cell mediated autoimmunity: molecular: interactions and therapeutic implications. J Autoimmun 1993, 3:501-506.
4. Kotzin BL: Systemic lupus erythemtosus. Cell 1996, 85:303-306.
5. Goodnow CC: Balancing immunity and tolerance: deleting and tuning lymphocytes repertoires. Proc Natl Acad Sci USA 1996, 19:2264-2271.
6. Okamoto M, Murakami M, Shimizu A, Ozaki S, Tsubata T, Kumagai S, Honjo T: A transgenic model of autoimmune hemolytic anemia. J Exp Med 1992, 175:71-79.
7. Murakami M, Tsubata T, Okamoto M, Shimizu A, Kumagai S, Imura H, Honjo T: Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice. Nature 1992, 357:77-80.
8. Herzen berg LA, Stall AM, Lalor PA, Sidman C, Moore WA, Parks DR, Herzenberg LA: The Ly-1 B cell lineage. Immunol Rev 1986, 93:81-102.
9. Hardy RR, Hayakawa K: Development and physiology of Ly-1 B and its human homologue, Leu-1 B. Immunol Rev 1986, 93:53-79.
10. Murakami M, Tsubata T, Shinkura R, Nisitani S, Okamoto M, Yoshioka H, Usui T, Miyawaki S, Honjo T: Oral administration of lipopolysaccharides activates B-1 cells in the peritoneal cavity and lamina propria of the gut and induces autoimmune symptoms in an autoantibody transgenic mouse. J Exp Med 1994, 180:111-121.
11. Murakami M, Nakajima K, Yamazaki K, Muraguchi T, Serikawa T, Honjo T: Effect of breeding environments on generation and activation of autoreactive B-1 cells in anti-red blood cell autoantibody transgenic mice. J Exp Med 1997, 185:791-794. This report demonstrated that peritoneal and gut B-1 cells were activated by enteric bacteria, suggesting the importance of environmental factors in the development of autoimmunity.
12. Kopf M, Brombacher F, Hodgkin-PD, Ramsay AJ, Milbourne EA, Dai-WJ, Ovington KS, Behm-CA, Kohler G, Young IG, Matthaei KI: IL-5-deficient mice have a developmental defect in CD5+B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity 1996, 4:501-506.
13. Velupillai P, Sypek J, Harn D: Interleukin-12 and-10 and IFN-γ regulate polyclonal and ligand-specific expansion of murine B-1 cells. Infect Immun 1996, 64:4557-4560.
14. Nisitani S, Tsubata T, Murakami M, Honjo T: Administration of interleukin-5 or-10 activates peritoneal B-1 cells and induces autoimmune hemolytic anemia in anti-erythrocyte autoantibody-transgenic mice. Eur J Immunol 1995, 25:3047-3052.
15. Lindstrom JM, Seybold VA, Lennon S, Whittingham S, Duane DD: Antibody to acetylcholine receptor in myasthenia gravis: prevalence, clinical correlates, and diagnostic value. Neurology 1976, 26: 1054-1059.
16. Vincent A, Newsom-Davis J: Anti-acetylcholine receptor antibodies. J Neurosurg Psychiatry 1980, 43:590-600.
17. Gu D, Wogensen L, Calcutt NA, Xia C, Zhu S, Merlie JP, Fox HS, Lindstrom J, Powell HC, Sarvetnick N: Myasthenia-like syndrome induced by expression of interferon γ in the neuromuscular junction. J Exp Med 1995, 181:547-557.
18. Balasa B, Deng C, Bradley LM, Dalton DK, Christadoss P, Sarvetnick N: Interferon γ (IFN-γ) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice. J Exp Med 1997, 186:385-391. IFN-γ KO mice did not suffer from experimental MG, whereas anti-AChR antibodies were detected and MG occurred in wild-type mice by repeated immunization of AChR. This study suggests that IFN-γ is necessary for the development of experimental MG.
19. Trinchieri G, Perussia B: Immune interferon: a pleiotropic lymphokine with multiple effects. Immunol Today 1985, 6:131-136.
20. Lindstrom JM, Shelton D, Fujii Y: Myasthenia gravis. Adv Immunol 1988, 42:233-284.
21. Isenberg D, Williams W, Axford J, Bakimer R, Bell D, Casaseca GT, Diamond B, Ebling F, Hahn B, Harkiss G: Comparison of DNA antibody idiotypes in humans sera: an international collaborative study of 19 idiotypes from 11 different laboratories. J Autoimmun 1990, 3:393-414.
22. Zhang GX, Xiao BG, Bakhiet M, Van der Meide P, Wigzell H, Link H, Olsson T: Both CD4+ and CD8+ T cells are essential to induce experimental autoimmune myasthenia gravis. J Exp Med 1996, 184:349-356.
23. Link J: Interferon-gamma, interleukin-4 and transforming-beta mRNA expression in multiple sclerosis and myasthenia gravis. Acta Neurol Scand Suppl 1994, 158:1-58.
24. Erikson J, Radic MZ, Camper SA, Hardy RR, Carmack C, Weigert M: Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice. Nature 1991, 349:331-335.
25. Chen C, Radic MZ, Erikson J, Camper SA, Litwin S, Hardy RR, Weigert M: Deletion and editing of B cells that express antibodies to DNA. J Immunol 1994, 152:1970-1982.
26. Gay D, Saunders T, Camper S, Weigert M: Receptor editing: an approach by autoreactive B cells to escape tolerance. J Exp Med 1993, 177:999-1008.
27. Tsao BP, Ohnishi K, Cheroutre H, Mitchell B, Teitell M, Mixter P, Kronenberg M, Hahan BH: Failed self-tolerance and autoimmunity in IgG anti-DNA transgenic mice. J Immunol 1992, 149:350-358.
28. Offen D, Spatz L, Escowitz H, Factor S, Diamond B: Induction of tolerance to an IgQ autoantibody. Proc Natl Acad Sci USA 1992, 89:8332-8336.
29. Cornall RJ, Goodnow CC, Cyster JG: The regulation of self-reactive B cells. Curr Opin Immunol 1995, 7:804-811.
30. Pisetsky DS, Jelinek DF, McAnally LM, Reich CF, Lipsky PE: In vitro autoantibody production by normal adult and cord blood B cells. J Clin Invest 1990, 85:899-903.
31. He X, Goronzy JJ, Weyand CM: The repertoire of rheumatoid factor-producing B cells in normal subjects and patients with rheumatoid arthritis. Arthritis Rheumatol 1993, 36:1061-1069.
32. Hirohata S, Inoue T, Ito K: Frequency analysis of human peripheral blood B cells producing autoantibodies: differential activation requirements of precursors for B cells producing IgM-RF and anti-DNA antibody. Cell Immunol 1991, 138:445-455.
33. Finck B, Linsley P, Wofsy D: Treatment of murine lupus with CTLA4lg. Science 1991, 265:1225-1227.
34. Lenshow DJ, Ho SC, Sattar H, Rhee L, Gray G, Nabavi N, Herold KC, Bluestone JA: Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the non-obese diabetes mouse. J Exp Med 1995, 181:1145-1155.
35. Cross AH, Giard TJ, Giacoletto KS, Evans RJ, Keeling RM, Lin RF, Trotter JL, Karr RW: Long term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-Fc supports a key role for CD28 costimulation. J Clin Invest 1995, 95:2783-2789.
36. Ma J, Xu J, Madaio MP, Peng Q, Zhang J, Grewal IS, Flavell RA, Craft J: Autoimmune lpr/lpr mice deficient in CD40 ligand: spontaneous Ig class switching with dichotomy of antibody responses. J Immunol 1996, 157:417-426.
37. Govermann J, Woods A, Larson L, Weiner LP, Hood L, Zȧller DM: Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 1993, 72:551-560.
38. Lafaille JJ, Nagashima K, Katsuki M, Tonegawa S: High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell 1994, 78: 399-408.